Fmr Llc

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 9.24M shares
Security Ownership: 5.9%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-08-06 - FMR LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.24M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 5.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	5.9%		$23.1M	9.24M			$2.50	13G	6/30/2025	6 Aug 2025 11:56:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$21M	9.24M	+9,130,557	+8430%	$2.27	Q2 2025
3/31/2025	0%	0%	$68.9K	108K	-198,472		$0.64	Q1 2025
12/31/2024	0%	+0%	$316K	307K	+22,476	+7.91%	$1.03	Q4 2024
9/30/2024	0%	+0%	$335K	284K	+41,949	+17.3%	$1.18	Q3 2024
6/30/2024	0%	+0%	$296K	242K	+59,281	+32.4%	$1.22	Q2 2024
3/31/2024	0%	0%	$399K	183K	-382,247	-67.6%	$2.18	Q1 2024
12/31/2023	0%	0%	$876K	565K	-142,644	-20.1%	$1.55	Q4 2023
9/30/2023	0%	0%	$913K	708K	-19,412	-2.67%	$1.29	Q3 2023
6/30/2023	0%	+0%	$1.25M	727K	+21,683	+3.07%	$1.72	Q2 2023
3/31/2023	0%	0%	$1.07M	706K	-10,949	-1.53%	$1.51	Q1 2023
12/31/2022	0%	+0%	$1.15M	717K	+15,087	+2.15%	$1.60	Q4 2022
9/30/2022	0%		$1.02M	702K	-1,612	-0.23%	$1.45	Q3 2022
6/30/2022	0%		$1.29M	703K	+1,367	+0.19%	$1.83	Q2 2022
3/31/2022	0%	+0%	$1.87M	702K	+165,382	+30.8%	$2.67	Q1 2022
12/31/2021	0%	0%	$2.32M	536K	-509,185	-48.7%	$4.33	Q4 2021
9/30/2021	0%		$5.32M	1.05M			$5.09	Q3 2021
6/30/2021	0%		$6.62M	1.05M			$6.33	Q2 2021
3/31/2021	0%		$8.08M	1.05M			$7.73	Q1 2021
12/31/2020	0%	+0%	$6.85M	1.05M	+220,700	+26.8%	$6.55	Q4 2020
9/30/2020	0%	0%	$5.49M	825K	-4,066	-0.49%	$6.65	Q3 2020
6/30/2020	0%		$6.91M	829K	+366	+0.04%	$8.33	Q2 2020
3/31/2020	0%		$6.36M	829K			$7.67	Q1 2020
12/31/2019	0%	0%	$6.89M	829K	-56,081	-6.34%	$8.31	Q4 2019
9/30/2019	0%	0%	$6.53M	885K	-438,523	-33.1%	$7.38	Q3 2019
6/30/2019	0%	0%	$14.8M	1.32M	-815,568	-38.1%	$11.22	Q2 2019
3/31/2019	0%	-0.01%	$23M	2.14M	-3,785,652	-63.9%	$10.75	Q1 2019
12/31/2018	0.01%	0%	$89.5M	5.92M	-820,122	-12.2%	$15.10	Q4 2018
9/30/2018	0.01%	+0%	$125M	6.74M	+900,927	+15.4%	$18.50	Q3 2018
6/30/2018	0.02%	+0%	$134M	5.84M	+51,953	+0.9%	$22.86	Q2 2018
3/31/2018	0.02%	+0%	$165M	5.79M	+30,379	+0.53%	$28.45	Q1 2018
12/31/2017	0.01%	+0%	$122M	5.76M	+231,189	+4.18%	$21.11	Q4 2017
9/30/2017	0.01%	+0%	$100M	5.53M	+17,646	+0.32%	$18.17	Q3 2017
6/30/2017	0.01%	+0%	$85.4M	5.51M	+34,732	+0.63%	$15.50	Q2 2017
3/31/2017	0.01%	+0%	$94.6M	5.48M	+17,375	+0.32%	$17.27	Q1 2017
12/31/2016	0.01%	+0%	$60M	5.46M	+17,090	+0.31%	$10.99	Q4 2016
9/30/2016	0.01%	+0%	$85.4M	5.44M	+30,097	+0.56%	$15.68	Q3 2016
6/30/2016	0.01%	+0%	$55.3M	5.41M	+1,484	+0.03%	$10.21	Q2 2016
3/31/2016	0.01%	+0%	$69.8M	5.41M	+8,038	+0.15%	$12.90	Q1 2016
12/31/2015	0.02%	+0.02%	$113M	5.4M	+5,403,643	NEW	$20.87	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.